Results 181 to 190 of about 722,784 (293)

Quantitative synthesis of the effects of drought on community composition and species interactions in terrestrial ecosystems

Oikos, EarlyView.
Droughts, increasingly frequent under human‐driven climate change, are expected to intensify globally. Both pulsed and prolonged droughts can strongly affect organismal survival and population dynamics, potentially altering terrestrial communities and ecosystems.
Mattheau S. Comerford, Kate Nash, Averie St. Germaine, Colin Andrews, Tyler S. Barr, Jonathan Dain, Alyssa Gonclaves, Amy, Jones, Cooper Kimball‐ Rhines, William Maguire, Alexander Richards, Emma Schneider, Alexis Wilkes, Mayra C. Vidal   +14 more
wiley   +1 more source

The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLD. [PDF]

JHEP Rep
Tiniakos DG, Bedossa P, Arola J, Davies S, Gouw ASH, Guido M, Lackner C, Schirmacher P, Terracciano L, Blain A, Wonders K, Anstee QM, Ratziu V, Paradis V.   +13 more
europepmc   +1 more source

Systems of reciprocity in human–ocean relationships: Across time, place, language and culture

People and Nature, EarlyView.
Abstract In the face of large‐scale marine environmental challenges, solutions that meaningfully capture the complexity of socio‐cultural and economic factors contributing to such issues—and their solutions—are urgently needed. This scoping review explores examples of reciprocity in human–ocean relationships to inform the conceptual underpinning and ...
Kianna M. Gallagher, Rachel Kelly, Claire Konkes, Gretta T. Pecl   +3 more
wiley   +1 more source

L-carnitine in metabolic dysfunction-associated steatotic liver disease: mechanisms and therapeutic potential. [PDF]

Front Nutr
Chen C, Zou J, Li L, Liu S, Liu Z, Yao L, Peng P, Liang J, Chen Z, Huang H, Huang J.   +10 more
europepmc   +1 more source

Evaluation of Pathogenic Variants Associated With Monogenic Disorders of Dyslipidemia in Patients With Well Characterised MASLD. [PDF]

Liver Int
Schwantes-An TH, Abreu MA, Neuschwander-Tetri BA, Wang J, Guo X, Tan J, Hegele RA, Davidson NO, Lotta L, Verweij N, Yates KP, Rotter JI, Chalasani N.   +12 more
europepmc   +1 more source

NASH in contrast [PDF]

Lab Animal, 2019
openaire   +2 more sources

From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies

Portal Hypertension &Cirrhosis, EarlyView.
This review examines the epidemiological shift from hepatitis B virus (HBV) to metabolic dysfunction‐associated steatotic liver disease (MASLD) as the leading cause of cirrhosis globally. It highlights the distinct pathogenic mechanisms between HBV and MASLD cirrhosis and discusses evolving diagnostic tools and therapeutic strategies tailored to the ...
Hanqi Yu, Hongfan Ding, Yang Huang, Haoze Cao, Yuan Ding, Weilin Wang   +5 more
wiley   +1 more source

Multi-omics reveals an association of the gut butyrate-IDO1-tryptophan axis with Yinchenhaotang plus Zexietang-ameliorated NASH in a microbiota-dependent manner. [PDF]

Chin Med
Liu W, Sha X, Zhao N, Liu B, Yang G, Jia L, Sui G.   +6 more
europepmc   +1 more source

Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Portal Hypertension &Cirrhosis, EarlyView.
MASLD is the most prevalent chronic liver disease worldwide, yet effective pharmacological treatments remain limited. Hyperuricemia is now recognized as a key driver of hepatic steatosis, inflammation, and fibrosis, with elevated serum uric acid levels independently predicting hepatocellular carcinoma and liver‐related mortality.
Rong Wang, Zhenyu Liu, Jun Lin, Weijing Zhang, Xianzhi Liu, Tong Zhang   +5 more
wiley   +1 more source

Perspectives of Indian Gastroenterologists and Hepatologists on Nonalcoholic Fatty Liver Disease Diagnosis and Management: Insights From the Nationwide Web-Based Cross-Sectional DRIVE Survey.

Interact J Med Res
Arora A, Garje Y, Shaikh S, Dharmadhikari S, Khandhedia C, Markandeywar N, Mane A, Mehta SC, Kumar A.   +8 more
europepmc   +1 more source